Expression and Function of the Megakaryocyte Growth and Development Factor Receptor in Acute Myeloid Leukemia Blasts

References

• Löwenberg B., Tow I.P. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281–292
   PubMed Web of Science ®Google Scholar
• Budel L.M., Touw I.P., Delwel R., Löwenberg B. Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 1989; 74: 2668–2673
   PubMed Web of Science ®Google Scholar
• Wang C., Curtis J.E., Geissler E.N., McCulloch E.A., Minden M.D. The expression of the proto-oncogene c-kit in the blast cells of acute myeloblasts leukemia. Leukemia 1989; 3: 699–702
   PubMed Web of Science ®Google Scholar
• Ikeda H., Kanakura Y., Tamaki T., Kuriu A., Kitayama H., Ishikawa J., Kanayama T., Yonezawa T., Tarui S., Griffin J.D. Expression and functional role of the proto-oncogene c-kit in acute myeloblasts leukemia cells. Blood 1991; 78: 2962–2968
   PubMed Web of Science ®Google Scholar
• Vigon I., Mornon J.P., Cocault L., Mitjavila M.T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proceedings of the National Academy of Sciences USA 1992; 89: 5640–5644
   PubMed Web of Science ®Google Scholar
• Bartley T.D., Bogenberger J., Hunt P., Li Y.-S., Lu H.S., Martin F., Chang M.-S., Samal B., Nichol J.L., Swift S., Johnson J., Hsu R.-Y., Parker P., Suggs S., Skrine J.D., Merewether L.A., Clogston C., Hsu E., Hokom M.M., Hornkohl A., Choi E., Pangelinan M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Xie C., Shutter J., Chute H., Basu R., Selander L., Trollinger D., Sieu L., Padila D., Trail G., Elliot G., Izumi R., Covey T., Crouse J., García A., Xu W., Del Castillo J., Biron J., Cole S., Hu M C.-T., Pacifici R., Ponting I., Saris C., Wen D., Yung Y.P., Lin H., Bosselman R.A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117–1124
   PubMed Web of Science ®Google Scholar
• de Sauvage F.J., Hass P.E., Spencer S.D., Malloy B.E., Gurney A.L., Spencer S.A., Darbonne W.C., Henzel W.J., Wong S.C., Kuang W.-J., Oles K.J., Hultgren B., Solberg L.A., Jr., Goeddel D.V., Eaton D.L. Stimulation of megakarocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature (Lond.) 1994; 369: 533–538
   PubMed Web of Science ®Google Scholar
• Lok S.L., Kaushansky K., Holly R.D., Kuijper J.L., Lofton-Day C.E., Oort P.J., Grant F.J., Heipel M.D., Burkhead S.K., Kramer J.M., Bell L.A., Sprecher C.A., Blumberg H., Johnson R., Prunkard D., Ching A.F.T., Mathewes S.L., Bailey M.C., Forstrom J.W., Buddie M.M., Osborn S.G., Evans S.J., Sheppard P.O., Presnell S.R., O'Hara P.J., Hagen F.S., Roth G.J., Foster D.C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature (Lond.) 1994; 369: 565–568
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Lok S.L., Holly R.D., Broudy V.C., Lin N., Bailey M.C., Forstrom J.W., Buddie M.M., Oort P.J., Hagen F.S., Roth G.J., Papayannopoulou T., Foster D.C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature (Lond.) 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar
• Wendling F., Maraskovsky E., Debill N., Florindo C., Teepe M., Tlteux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. c-Mpl ligand is a humoral regulator of megakarocytopoiesis. Nature (Lond.) 1994; 369: 574–574
   PubMed Web of Science ®Google Scholar
• Stewart C.C. Clinical applications of flow cytometry. Immunologic methods for measuring cell membrane and cytoplasmic antigens. Cancer 1992; 69(Suppl)1543–1552
   PubMed Web of Science ®Google Scholar
• Terstappen L.W., Safford M., Konemann S., Loken M.R., Zurlutter K., Buchner T., Hiddemann W., Wormann B. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1992; 6: 70–80
   PubMed Web of Science ®Google Scholar
• Reading C.L., Estey E.H., Huh Y.O., Claxton D.F., Sanchez G., Terstappen L.W., O'Brien M.C., Baron S., Deisseroth A.B. Expression of unusual immunophe-notype combinations in acute myelogenous leukemia. Blood 1993; 81: 3083–3090
   PubMed Web of Science ®Google Scholar
• Mignotte V., Vigon I., de Crevecoeur E.B., Romeo P.-H., Lemarchandel V., Chretien S. Structure and transcription of the human c-mpl gene (MPL). Genomics 1994; 20: 5–12
   PubMed Web of Science ®Google Scholar
• Vigon I., Dreyfus F., Melle J., Viguie F., Ribrag V., Cocault I., Souyn M., Gisselbrecht S. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 1993; 82: 877–883
   PubMed Web of Science ®Google Scholar
• Gunji H., Kharbanda S., Kufe D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. Cancer Research 1991; 51: 741–743
   PubMed Web of Science ®Google Scholar
• Tosi P., Visani G., Ottaviani E., Manfori S., Zinzani P.L., Tura S. Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells. Leukemia 1994; 8: 2076–2082
   PubMed Web of Science ®Google Scholar
• Wyllie A.H., Morris R.G., Smith A.L., Dunlop D. Chromatin cleavage in association with condensed chromatin morphology and dependence on macromolecular synthesis. Journal of Pathology 1984; 142: 61–11
   PubMed Web of Science ®Google Scholar
• Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. Journal of Immunological Methods 1991; 139: 271–279
   PubMed Web of Science ®Google Scholar
• Morella K.K., Bruno E., Kumaki S., Lai C-F., Fu J., Wang H-M., Murray L., Hoffman R., Timour M., Benit L., Gisselbracht S., Zhuang H., Wojchowski D.M., Baumann H., Gearing D.P. Signal transduction by the receptors for thrombopoietin (c-mpl) and interleukin-3 in hematopoietic and nonhematopoietic cells. Blood 1995; 86: 557–571
   PubMed Web of Science ®Google Scholar
• Wetzler M., Talpaz M., Van Etten R.A., Hirsh-Ginsberg C., Beran M., Kurzrock R. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. Journal of Clinical Investigation 1993; 92: 1925–1939
   PubMed Web of Science ®Google Scholar
• Wetzler M., Baer M.R., Bernstein S.H., Blumenson L., Stewart C., Barcos M., Mrozek K., Block A.W., Herzig G.P., Bloomfield C.D. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. Journal of Clinical Oncology 1997; 15: 2262–2268
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 1992; 80: 1750–1757
   PubMed Web of Science ®Google Scholar
• Bouscary D., Prudhomme C., Quesnel B., Melle J., Picard F., Dreyfus F. c-mpl expression in hematologic malignancies. Leukemia and Lymphoma 1995; 17: 19–26
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Kato T., Ikeda H., Ishikawa J., Horikawa Y., Hashimoto K., Moriyama Y., Tsujimura T., Nishiura T., Miyazaki H., Matsuzawa Y. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995; 86: 703–709
   PubMed Web of Science ®Google Scholar
• Quentmeier H., Zaborski M., Graf G., Ludwig W.D., Drexler H.G. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia 1996; 10: 297–310
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Kato T., Ikeda H., Horikawa Y., Ishikawa J., Kitayama H., Nishiura T., Tomiyama Y., Miyazaki H., Matsuzawa Y. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocyte differentiation of acute myeloblastic leukemia cells. Blood 1996; 88: 3074–3082
   PubMed Web of Science ®Google Scholar
• Brawerman G. Determinants of messenger RNA stability. Cell 1987; 48: 5–6
   PubMed Web of Science ®Google Scholar
• Ferrari S., Tagliafico E., D'Inca M., Ceccherelli G., Manfredini R., Selleri L., Donelli A., Sacchi S., Torelli G., Torelli U. Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin in leukemic blast cells. Cancer Research 1990; 50: 1988–1991
   PubMed Web of Science ®Google Scholar
• Ferrari S., Mariano M.T., Tagliafico E., Sarti M., Ceccherelli G., Selleri L., Merli F., Narni F., Donelli A., Torelli G., Torelli U. Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. Blood 1988; 72: 873–876
   PubMed Web of Science ®Google Scholar
• Wetzler M., Kurzrock R., Estrov Z., Estey E., Talpaz M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leukemia Research 1995; 19: 23–34
   PubMed Web of Science ®Google Scholar
• Dokter W.H.A., Borger P., Hendriks D., van der Horst I., Ruud Halie M., Vellenga E. Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level. Blood 1992; 80: 2721–2728
   PubMed Web of Science ®Google Scholar
• Murohashi I., Tohda S., Suzuki T., Nagata K., Yamashita Y., Nara N., Aoki N. Expression of interleukin-lp receptors on blast cells in acute myeloblastic leukemia: comparison with interleukin-1β proliferative activity. Cancer Research 1989; 49: 3431–3435
   PubMed Web of Science ®Google Scholar
• Budel L.M., Touw I.P., Delwel R., Clark S.C., Löwenberg B. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood 1989; 74: 565–571
   PubMed Web of Science ®Google Scholar
• Bernstein S.H., Baer M.R., Lawrence D., Herzig G.P., Bloomfield C.D., Wetzler M. Serial determination of thrombopoietin (TPO), IL-3, IL-6, IL-11 and leukemia inhibitory factor (LIF) levels in patients undergoing chemotherapy for acute myeloid leukemia (AML). Blood 1995; 86: 46a, Abstr
   Google Scholar
• Hunt P., Li Y.S., Nichol J.L., Hokom M.M., Bogenberger J.M., Swift S.E., Skrine J.D., Hornkohl A.C., Lu H., Clogston C., Merewether L.A., Johnson M.J., Parker V., Knudten A., Farese A., Hsu R.Y., García A., Stead R., Bosselman R.A., Bartley T. Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 1995; 86: 540–547
   PubMed Web of Science ®Google Scholar
• Nichol J.L., Hokom M.M., Hornkohl A., Sheridan W.P., Ohashi H., Kato T., Li Y.S., Bartley T.D., Choi E., Bogenberger J., Skrine J.D., Knudten A., Chen J., Trail G., Sleeman L., Cole S., Grampp G., Hunt P. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. Journal of Clinical Investigation 1995; 95: 2973–2978
   PubMed Web of Science ®Google Scholar
• Ulich T.R., del Castillo J., Yin S., Swift S., Padilla D., Senaldi G., Bennett L., Shutter J., Bogenberger J., Sun D., Samal B., Shimamoto G., Lee R., Steinbrink R., Boone T., Sheridan W.T., Hunt P. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995; 86: 971–976
   PubMed Web of Science ®Google Scholar
• Farese A.M., Hunt P., Boone T., MacVittie T.J. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995; 86: 54–59
   PubMed Web of Science ®Google Scholar
• Basser R.L., Rasko J.E., Clarke K., Cebon J., Green M.D., Hussein S., Alt C., Menchaca D., Tomita D., Marty J., Fox R.M., Begley C.G. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 1996; 348(9037)1279–1281
   PubMed Web of Science ®Google Scholar
• Geller R.B. Use of cytokines in the treatment of acute myelocytic leukemia: A critical review. Journal of Clinical Oncology 1996; 14: 1371–1382
   PubMed Web of Science ®Google Scholar
• Cairo M.S., Suen Y., Sender L., Gillan E.R., Ho W., Plunkett J.M., van de Ven C. Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment. Blood 1992; 19: 1869–1873
   Google Scholar
• Greendyke R.M., Sharma K., Gifford F.R. Serum cytokine levels in patients with neutropenia. Archives of Pathology and Laboratory Medicine 1994; 118: 1193–1195
   PubMed Web of Science ®Google Scholar
• Testa U., Martucci R., Rutella S., Scambia G., Sica S., Benedetti Panici P., Pierelli L., Menichella G., Leone G., Mancuso S., Peschle C. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 1994; 84: 3532–3539
   PubMed Web of Science ®Google Scholar
• Ho A.D., Maruyama M., Maghazachi A., Mason J.R., Gluck S., Corringham R.E. Soluble CD4, soluble CD8, soluble CD25, lymphopoietic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation. Blood 1994; 84: 3550–3557
   PubMed Web of Science ®Google Scholar